Navigation Links
Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
Date:4/29/2009

as Nuvilex. Moving our discoveries into the world takes resources - investment capital, which has all but disappeared from the market because of the current economic downturn. If Citroxin takes root as envisioned, demand will outpace our manufacturing capabilities and it will be necessary for us to seek a commercial partner to move the product quickly into the marketplace."

Citroxin is a eco-friendly surface cleaner. The Company's viral testing to date has been led by Sagar M. Goyal, D.V.M., Ph.D. at the University of Minnesota. Dr. Goyal has investigated the use of Citroxin to treat viral subtypes of SIV (H1N1). In Dr. Goyal's first experiment, his team evaluated the ability of Citroxin (dilutions of 1:10 and 1:100) to inhibit the replication of SIV H1N1 in vitro. Compared to the controls, high concentrations of Citroxin (1:10 dilution) were found to be virucidal for SIV growing in MDCK (Madin-Darby canine kidney) cells.

The Company, in conjunction with international based academic researchers, has also treated H9N9 AIV with Citroxin. In the AIV H9N9 experiments, Citroxin also served as a better virucidal agent when it received a smaller viral challenge (1000, 100, and 10 tissue culture infectious dose50, or TCID50, of virus).

"Although Citroxin is not yet proven to be immunogenic, experiments do suggest that Citroxin can serve as an effective cleaner or disinfectant for surfaces that may have come into contact with SIV, AIV, or other types of virus particles," said Dr. Morello. "We are ready, willing and able to help the global public health community in combating the swine flu outbreak."

About Nuvilex, Inc.

Nuvilex, formerly eFoodSafety.com, Inc. is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare p
'/>"/>

SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nuvilex, Inc. Announces Investor Conference Call and Open House
2. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
3. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
4. Nuvilex Provides Conference Call Replay Information
5. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
6. Nuvilex Infinitink Tattoo Ink Featured on PBS alt.news 26:46 TV Program
7. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
8. New advances in cancer research to be highlighted at University of Leicester
9. Male Cosmetic Surgery Slows Down While Female Cosmetic Surgery Advances
10. Survey Results: Health Care Technology Advances as Physician Frustration Grows
11. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... Los Angeles, CA (PRWEB) July 27, 2014 ... of Summer Tickets at The Forum in Inglewood, California on ... new album and diehard fans can expect to hear songs from ... 5 Seconds of Summer concert in Inglewood, California at The Forum ... Find tickets starting at 10:00 a.m. today local time TicketDown.com. ...
(Date:7/27/2014)... Manchester have discovered why medication to treat asthma and pneumonia ... Medicine , show that drugs widely used to treat lung ... the UK pneumonia, which is caused by an infection, affects ... serious for babies, young children, the elderly, smokers and those ... million people in the UK are affected by asthma and ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 The North ... is estimated at $1570 million in 2014, and it ... a CAGR of 4.64%. The report incorporates the factors ... detailed expectations of growth rates and projected total expenditure. ... in the global markets. Apart from the general overview ...
(Date:7/27/2014)... 27, 2014 The European Agricultural Adjuvants ... Europe with analysis and forecast of revenue. The agricultural ... around $509.4 million in 2013 to $657.1 million by ... 2018. , Browse through the TOC of the European ... the in-depth analysis provided. It also provides a glimpse ...
(Date:7/27/2014)... July 27, 2014 Metachromatic leukodystrophy ... lysosomal storage disease which is commonly listed in ... the sphingolipidoses as it affects the metabolism of ... myelin, the fatty covering which acts as an ... peripheral nervous systems. MLD involves cerebroside sulfate accumulation. ...
Breaking Medicine News(10 mins):Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:Drugs used to treat lung disease work with the body clock 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 5Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 2Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 3Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 5
... at risk for the disease, as well as ways to prevent ... osteoporosis. ,1. MYTH: Only women get osteoporosis ... this condition, theres also a very significant portion of men who ... suffer from osteoporosis, accounting for 20 percent of those diagnosed with ...
... US-based Redux Beverages said it would be marketing. Well, only it was ... drink. ,In September last year it announced the launch ... illegal drug. ,Jamey Kirby, the drink's inventor, said the name ... session at 1 o'clock in the morning. ,"It's an ...
... how nerve cells signal to one another could rewrite the ... at Weill Cornell Medical College and Yale University. ... journal Science, suggests that a key cellular enzyme called dynamin ... had previously assumed. ,Dynamin has long been a ...
... and additional risk factors for heart disease may ... two , if their current treatment combines the ... amlodipine, researchers reported at the American Heart Association's ... Outcomes Research in Cardiovascular Disease and Stroke. ...
... The Health and Family Welfare Minister, Dr. Anbumani ... Nursing Personnel today , said that under the ... requires about 200,000 nursing personnel to provide comprehensive ... achieve the requirements of NRHM, State Governments have ...
... Sensitive issues, poignant emotions and subjects that are not ... body were the mainstay of the international film festival ... on its first day Saturday. , ,Brought ... Bharati Corporation, the Mac Arthur Foundation and UNESCO, the ...
Cached Medicine News:Health News:7 Common Myths About Osteoporosis 2Health News:7 Common Myths About Osteoporosis 3Health News:'Cocaine' Turns 'Censored' and Remains 'energy Drink' 2Health News:'Cocaine' Turns 'Censored' and Remains 'energy Drink' 3Health News:Study Revises Dynamin's Role in Nerve Cell Function 2Health News:Study Revises Dynamin's Role in Nerve Cell Function 3Health News:One Pill may Be Better Than Two for Treating Patients With High Blood Pressure 2Health News:One Pill may Be Better Than Two for Treating Patients With High Blood Pressure 3Health News:Film Festival on Gender Sexuality Draws Crowds 2
(Date:7/24/2014)... July 24, 2014  IRIDEX Corporation (NASDAQ: ... second quarter 2014 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, July 31, 2014 ... other business developments. Interested parties may access ...
(Date:7/24/2014)... July 24, 2014 Omnicell, Inc. (NASDAQ: ... medication and supply management solutions and analytics software ... July 31, to discuss the Company,s Second Quarter ... Quarter 2014 earnings conference call and webcastWhen: ... Randall Lipps, chairman, president and chief executive officer ...
(Date:7/24/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based ... results for the second quarter ended June 30, 2014. ... of $6.5 million in the second quarter of 2014, an ... , Total revenues of $13.3 million for the six months ... same period in 2013 , Total revenues generated from ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... MicroCHIPS, Inc., a developer of innovative drug delivery ... Office and Trademark Office has granted U.S. Patent No. ... This patent in conjunction with U.S. Patent No. 7,070,590 ... reservoir-based medical devices used for implantable drug delivery systems. ...
... Promidian, a management consulting firm focused on ... survey findings about the increasing interest in the ... that is rapidly gaining nationwide attention for its ... care—while reducing costs. The Promidian ...
Cached Medicine Technology:MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems 2Promidian Survey Finds Growing Support for Patient-Centered Medical Home 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: